The next Paul Torrens Health Forum brings together visionary health system leaders and cutting-edge entrepreneurs for a fast-paced, idea-driven conversation on how American healthcare is being fundamentally reshaped - what true disruption looks like, how innovation can be responsibly integrated into care delivery, and what leaders, clinicians, and innovators must do next. Building on this discussion, several healthcare entrepreneurs will deliver rapid pitches, each offering a concise overview of a product or service designed to address today’s most pressing healthcare challenges. If you want to understand where healthcare is headed, and learn more about who is actively building that future, this is a forum you won’t want to miss.
SCROLL DOWN FOR REGISTRATION
Featured Speakers:
Omkar Kulkarni, MPH, Vice President and Chief Transformation & Digital Officer, CHLA
Marschall Runge, MD, PhD, Former CEO, Michigan Medicine
Guest Disruptors:
Melissa Hanna, JD, MBA, CEO, Mahmee
Eric Marton, Founder & CEO, Agentic Healthcare, Inc.
Ling Shao, Founder & CEO, SpectrumAi
SPEAKER BIOS
Omkar Kulkarni, Vice President and Chief Transformation & Digital Officer, CHLA
In his role, Omkar is responsible for leading transformative change across the organization by designing and implementing practical, innovative solutions to high-impact problems. Under his leadership, the Office of Transformation drives digital and operational transformation by developing and deploying transformative products that improve patient access, operational efficiency, financial performance, growth, team member engagement and patient family experience. Omkar joined CHLA in 2018 as CHLA’s inaugural Chief Innovation Officer and has led many initiatives to position CHLA as an innovator in pediatric care delivery.
He helped lead the enterprise rollout of telehealth in 2020 and also led the development of the Office of Virtual Care, the Digital Health Lab incubator, and the Digital Transformation/Digital Front Door strategy – a five-year strategic plan to leveraging accessible digital technology to enhance how CHLA engages patients and families in their care journey. Omkar also founded KidsX in 2019, through which more than 30 children’s hospitals have come together to accelerate the development of 52 innovative digital products focused on improving pediatric health.
Prior to joining CHLA, Omkar served as executive director of the Cedars-Sinai Accelerator powered by Techstars, where he helped build and launch the accelerator program. In that role, he evaluated over 3,000 health care start-ups and provided extensive mentoring, serving as the main liaison between the start-up community and Cedars-Sinai Medical Center. Omkar also led the performance improvement department at Cedars-Sinai for many years and has experience in financial process redesign at New York-Presbyterian Hospital. Omkar has a master’s degree in public health and health care management from Columbia University and a bachelor’s degree in business administration from George Washington University.
Marschall Runge, Former CEO, Michigan Medicine
Marschall Runge, MD, PhD is the former CEO of Michigan Medicine and Dean of the University of Michigan Medical School, and a practicing cardiologist. During his tenure in these leadership roles, Dr. Runge implemented transformative change and positioned Michigan Medicine and the Medical School internationally for continued success.
He earned his doctorate in molecular biology at Vanderbilt University and his medical degree from Johns Hopkins School of Medicine, where he also completed a residency in internal medicine. He was a cardiology fellow at the Massachusetts General Hospital and has been a physician-scientist for his entire career.
Dr. Runge is the author of over 250 publications and holds five patents for novel approaches to health care. An avid thriller reader, Runge has experienced many you-can’t-make-this-up events that inform his fictional and non-fiction writing alike. In addition to The Great Healthcare Disruption, Dr. Runge is the author of the gripping medical thriller, Coded to Kill.
Melissa Hanna, Cofounder and CEO, Mahmee
Melissa Hanna, JD, MBA, is the Cofounder and CEO of Mahmee, a tech-enabled maternal and infant healthcare company delivering continuous, wraparound support through virtual services and modern clinics across California. A national leader in value-based maternity care, she developed one of the first wraparound care bundles in the U.S. and pioneered the employed workforce model for doulas and lactation consultants, advancing workforce development and hybrid care delivery statewide. She has also led major partnerships with Blue Shield of California, HealthNet, Providence, Sutter, and Kaiser Permanente to expand access to coordinated maternal and infant care.
Her work has been featured in Entrepreneur, Fortune, USA Today, and Business Insider, and she has been honored by Inc.’s Female Founders 100, Managed Healthcare Executive’s Emerging Health Leaders, and Goldman Sachs’ Most Exceptional Entrepreneurs. Melissa holds an MBA from the Drucker School of Management and a JD from Southwestern Law School, where she teaches corporate and technology law.
Eric Marton, Founder & CEO, Agentic Healthcare, Inc.
Eric is a 25+ year veteran of the healthcare industry having led efforts in venture capital, private equity, health system strategy, hospital operations, medical group management, and M&A. Before founding Agentic Healthcare, Eric was a Partner at Wavemaker 360 – a venture capital firm investing in early stage healthcare companies in the areas of digital health, precision medicine, AI, data/analytics, and medical devices.
Over the years, Eric has served in numerous leadership roles: Chief Strategy Officer of the Verity Health System, CEO of the Verity Physician Network, CEO of Surgical Partners of California, Executive Director at the Cedars-Sinai Heart Institute, CEO of the California Heart Center at UCLA, and Managing Partner at Catalyst Venture Group. He is a member of the Board of Directors for several for-profit and non-profit organizations and Executive Advisor to several publicly traded companies. Eric is also a frequent speaker/panelist at industry conferences and guest lecturer for the schools of business, medicine, and public policy at UCLA and at USC.
Ling Shao, Founder & Former CEO, SpectrumAi
Ling Shao is the founder and former CEO of SpectrumAi, a digital health company dedicated to improving access to high-quality, outcomes-driven care for children on the autism spectrum. SpectrumAi recently achieved a successful acquisition by a publicly traded technology company that owns the largest electronic medical record (EMR) platform in the autism space - expanding the reach of its innovations across thousands of providers nationwide.
Under Ling’s leadership, SpectrumAi developed an intuitive, computer vision AI-enhanced video EMR that enables clinicians to capture objective behavioral data with greater precision and efficiency. By integrating advanced analytics and structured clinical data, the platform advances measurement-based care, supports reproducible outcomes, and contributes to the broader scientific movement toward data standardization in behavioral health.
Trained as an engineer, nurse and as a mother of four boys on the autism spectrum, Ling brings a uniquely interdisciplinary and deeply personal perspective to her work. Her mission centers on democratizing access to high-quality care through data transparency and evidence-aligned clinical infrastructure.
Ling holds an MBA from Harvard University, a BS in Nuclear Engineering with a minor in Biomedical Engineering from MIT and completed her training as a nurse in the U.S. Army.
Prior to founding SpectrumAi, Ling served as Chief Commercial Officer at Buoy Health, an AI-driven symptom navigation platform. She previously accelerated telehealth adoption at major health systems including Cleveland Clinic, Providence, and Atrium Health as SVP of Strategic Solutions at Amwell. Earlier in her career, she spent over a decade in senior leadership roles at UnitedHealthcare and Optum across product, clinical strategy, and commercialization. She began her career as a senior consultant at Booz Allen Hamilton and as a research nurse at Massachusetts General Hospital